One of the studies presented during Sunday morning’s Year in Review session highlighted work by investigators from the University of Toulouse in France that provides new insight into gender bias, which is seen in many autoimmune diseases.
“The use of antibiotics is affecting our microbiome and our health,” said Martin Blaser, MD, Director of the New York University Human Microbiome Program at the NYU School of Medicine. And it may have an impact on autoimmune diseases.
During Saturday’s Opening Lecture & Awards session, Jonathan Koch, who survived acute hemophagocytic lymphohistiocytosis, shared an impassioned message for how physicians can better partner with patients to enhance survival potential.
Successful Sjögren’s syndrome diagnosis and management requires a multi-disciplinary team and continues to be the most challenging of the rheumatic diseases to diagnose, according to two Sjögren’s specialists who spoke Sunday.
From the safety and efficacy of current and emerging therapies to new information on treatment targets, Tuesday’s Plenary Session III will feature a series of abstract presentations covering cutting-edge clinical and basic science research results.
A vast number of beneficial human genetic variants have evolved with regard to infectious diseases. These variants have helped the human race survive, but they could also be the cause of autoimmune and autoinflammatory diseases.
“It’s hard to compare what happens in one data set with another, but with the tools that we have today, you can apply a metric that can be interpreted across a large number of large data sets,” said Soham Al Snih, MD, PhD.